Companies related to Immunotherapy

We are a global allergy solutions company, pioneering in allergy research for more than 100 years.

Innovation in Immunotherapy to Treat Inflammation and Infection

BC Cancer provides a province wide, population-based cancer control program. Privacy & moderation: phsa.ca/privacy

Personalizing Treatments and Cures

Pioneering RNA cell therapy for autoimmune disease

Innovation for Advanced Therapies

The cell and gene therapy development and manufacturing organization within New York Blood Center Enterprises

Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.

Dedicated to science - Committed to your health

Media specialists providing cell culture solutions for industrial, clinical and research applications for over 50 years.

Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.

The leading Spatial Biology Software Platform for Precision Medicine.

Developing Innovative Cell Therapies Against Cancer

Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions

This page is no longer active. Please follow us at Emmes. Our new website is https://www.emmes.com/emmes-europe.

The First Cell-Centered Computational Model of Human Disease

Developing Next Generation mRNA Vaccines

Founded in 1953, CRI is the world's leading nonprofit dedicated to funding cancer immunotherapy research.

Innovative pharmaceutical company revolutionizing bladder cancer treatment

Cancer Immunotherapies by Design

An Australian-first bench-to-bedside medical research institute, translating medical discoveries into improved health.

The nation's first not-for-profit biomedical research organization

Curing Cancer

.

PIONEERING IMMUNOTHERAPY

We are a San Francisco-based Venture Studio reimagining drug discovery to develop transformative immunotherapies

Our passion drives us to provide new health solutions advancing human life

Modulating splicing in Immunotherapy

Enabling precision medicine to improve life for people with allergies

Providing high purity reagents and improved peptide binding services to drive your next HLA discovery.

Permanent Self-Vaccination Against Cancer

We support drug discovery through translational research across oncology and immuno-oncology.

Let's Build Better Cells Together

Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy

Harnessing the immune system to fight cancer

A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line)

Dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer

Science to Transform Lives

Science in Translation - We put inspiration into practice, finding viable solutions to complex challenges.

Unlocking the future of medicine

We are developing advanced therapies for cancer patients with critical unmet needs

A Member of the Roche Group

Expertise in Cell and Gene Therapies, based out of Montreal QC and Toronto ON.

Open cells to new possibilities: Accelerating cell therapy processes from discovery through manufacturing with Flowfect®

Immunotherapy Ventures

Harnessing more of the immune system for better cancer outcomes

Transforming imaging data into actionable predictions

Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates.

Pioneer in living medicines

Invectys a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers

Bringing Effective New Treatments And Options To Patients Who Need Them

The science driven BioPark at the heart of Europe.

Fate can be altered.

Harnessing the power of a semi-synthetic organism with an expanded genetic alphabet to develop protein therapeutics

Pioneers in Cell Therapy ASX:CHM

Simple Relief. Better Life.

Simple Relief. Better Life.

MAIA Biotechnology is a targeted therapy, immuno-oncology company focused on development of first-in-class drugs

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.

CREATING ANTIBODIES TOGETHER

#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation

#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation

Targeted delivery of nanoparticles for in vivo CAR T therapy

Presenting live and digital music events that raise awareness and funding for cancer treatment, research, and programs.

The Biotherapy Network

We combine multi-omics data, AI, computational biology, and MIDD for the next era of diagnosis and patient treatment.

Davidoff center, Beilinson hospital

Best-in-class treatment of HPV-cancer

We are the largest and best-equipped cancer treatment centre in West Africa. Radiotherapy | Brachytherapy | Chemotherapy

Destroying tumors by targeting cancer cell fitness.

A biotech company developing novel dermaceutical products for oncology patients undergoing clinical treatment

Reshaping the future of immunotherapies

People affected by prostate cancer need breakthroughs. Research is the only way we can turn this hope to reality.

Developing a portfolio of immune-educating therapies based on our DPX® platform to treat solid and hematologic cancers

From molecule to marketplace, accelerating biotech growth and gene therapies—one smart solution at a time.

Unravelling immune system function, one cell at a time

LRCG researches genetic abnormalities in acute leukaemia, assessing their diagnostic and prognostic value in trials.

A fully integrated biotech company at the forefront of pioneering cutting-edge immunotherapies.

Transforming medicine through engineered cellular therapies that restore, regenerate, and repair tissues and organs.

A unique full-service CDMO, setting new standards in Cell & Gene Therapy

Eliminating the obstacles in your path to optimal wellness.

Supercharging Immunotherapy

Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science

A clinical stage biotechnology company whose mission is to create safer and more efficacious cancer therapies.

is developing disruptive therapies to address critical unmet medical needs in cancer and infectious diseases.

Engineering the next-generation of T cell receptor therapies against cancer

Pioneering the future of immunotherapy.

Pioneering the future of immunotherapy.

Cutting-edge peer-reviewed research and analysis on genome editing and CRISPR biology.

Achieving a better cure for cancer by cellular immunotherapy

Viral-vector therapeutics engineered for genetic stability, immunogenicity, payload capacity, & scalable manufacturing.

evaxion.ai

Telesis Bio empowers researchers with the tools to rapidly and securely design, code, and create synthetic DNA and mRNA.

DISCOVERING AND DEVELOPING NEW IMMUNOTHERAPY AGENTS TO IMPROVE THE LIVES OF THOSE LIVING WITH CANCER.

DISCOVERING AND DEVELOPING NEW IMMUNOTHERAPY AGENTS TO IMPROVE THE LIVES OF THOSE LIVING WITH CANCER.

Developing allogeneic TCR-NK therapies for solid tumors

Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives.

Sharing knowledge. Sharing hope.

An integrated cell therapy Contract Testing, Development and Manufacturing Organization (CTDMO)

Improving the lives of pets and their families

An Immunotherapy Company